Jan 1, 2014 by Dave WilliamsonIs America Prepared for Obamacare's Debut?Enrolled Americans begin enjoying benefits of the Affordable Care Act on Jan. 1.
Dec 27, 2013 by Dave WilliamsonDiabetes Drug Partnership Amicable DivorceHere's why Bristol-Myers Squibb left AstraZeneca, and its foray into diabetes.
Dec 27, 2013 by Dave WilliamsonCould AbbVie's Hepatitis C Treatment Be in Trouble?Despite AbbVie's incredible hepatitis C cure rates, the competition could prove too much to handle.
Dec 27, 2013 by Dave WilliamsonAre New Obamacare Enrollees Now in Jeopardy Because of This Deadline?What will happen for Obamacare now that this deadline has passed?
Dec 27, 2013 by Dave WilliamsonCheap Viagra On the WayIs a cheap generic version of the famous little blue pill finally just around the corner?
Nov 14, 2013 by Dave Williamson and Alison SouthwickRanking 3 Big Pharmas' Bad NewsLet's play the Big Pharma rank-it game! Today's challenge: Which of these three companies had the worst news?
Nov 14, 2013 by Dave Williamson and Alison SouthwickPost-Plunge: Is Sarepta a Bad News Buy?Is Sarepta Pharmaceuticals' sell-off a great time to buy?
Nov 14, 2013 by Dave Williamson and Alison SouthwickWhat Was Behind Vanda's 80% Pop?Vanda popped on some very positive words from the Food and Drug Administration. Is there still room to run?
Nov 12, 2013 by Dave WilliamsonBristol-Myers Squibb's Radical TransformationBristol-Myers is pulling out of drug discovery in three massive patient population markets. What should investors think of the move?
Nov 12, 2013 by Dave Williamson and Alison SouthwickThe Next Rare-Disease Powerhouse?This rare-disease biopharmaceutical company just got a big new ace in its deck. Should investors be getting in today?
Nov 12, 2013 by Dave WilliamsonObesity Drug Deal Goes GlobalArena's obesity drug Belviq goes global, but is the opportunity really as big as it seems?
Nov 12, 2013 by Dave WilliamsonEveryone Wins With This Biotech BuyoutThis biotech buyout sent shares of both companies soaring. Should investors be jumping in?
Nov 12, 2013 by Dave Williamson and Alison Southwick1 Big Pharma Stock's Big, Bold MovesNovartis is selling off one of its major businesses. What does this mean for shareholders?
Nov 12, 2013 by Dave Williamson and Alison SouthwickMore Bad News for Intuitive Surgical?Could this bad press damage Intuitive Surgical for the long run?
Nov 10, 2013 by Dave WilliamsonWill Novartis Rip Itself Apart?Novartis could be selling off some of its divisions. How will investors be affected?
Nov 10, 2013 by Dave Williamson and Alison SouthwickMerck's Exciting Anti-Virus PipelineMerck's got a couple pieces of very promising antiviral news coming down its pipeline. Should investors be getting excited?
Nov 10, 2013 by Dave Williamson and Alison SouthwickIs Glaxo's China Nightmare Finally Ending?Could GlaxoSmithKline finally be off the hook in China?
Nov 10, 2013 by Dave Williamson and Alison SouthwickWhy Johnson & Johnson Is Paying the Department of Justice BillionsHere's what's behind Johnson & Johnson's colossal $2.2 billion settlement.
Nov 10, 2013 by Dave Williamson and Alison SouthwickWhat Ingredient Is the Government Removing From Your Diet?Could trans fats in foods soon be a thing of the past?
Nov 8, 2013 by Dave Williamson and Alison SouthwickObamacare's Unofficial Enrollment Data DramaDo these numbers show that the shockingly bad Obamacare online health insurance marketplace rollout was even worse than we thought?
